Dianexin

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameDianexin
Drug Alias Name地阿奈星Annexin A5 recombinant达艾克新DiannexinASP-8597
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionPhosphatidylserine agonists
TargetsPhosphatidylserine
Therapy Area/IndicationsRejection of renal transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAlavita
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlavita Pharmaceuticals IncAstellas Pharma Inc
Active IndicationsN/A
Inactive IndicationsRejection of renal transplantation

Other Information

ATC CodeN/A
Related LinksKEGG